Inventor · disambiguated record
Ryuichiro Ishitani
Also filed as: ISHITANI RYUICHIRO
7 granted patents·7 pending applications·41 citations·filing 2002–2023
81Inventor score
Top patents by PatentIndex Score
14 records- 0194US10550372B2Systems, methods and compositions for sequence manipulation with optimized functional CRISPR-Cas systemsBROAD INST INC·Filed 2016·Granted Feb 4, 2020·28 cites·36 claims
- 0286US11597919B2Systems, methods and compositions for sequence manipulation with optimized functional CRISPR-Cas systemsBROAD INST INC·Filed 2019·Granted Mar 7, 2023·2 cites·30 claims
- 0380US12258595B2Systems, methods and compositions for sequence manipulation with optimized functional CRISPR-Cas systemsBROAD INST INC·Filed 2022·Granted Mar 25, 2025·0 cites·30 claims
- 0478US7514240B2EGR-EGFR complexJAPAN SCIENCE & TECH AGENCY·Filed 2002·Granted Apr 7, 2009·7 cites·7 claims
- 0575US2024079099A1Inferring device, training device, inferring method, method of generating reinforcement learning model and method of generating molecular structurePREFERRED NETWORKS INC·Filed 2023·Application pending·0 cites
- 0674US10189843B2Fused pyrazole derivative having autotaxin inhibitory activityUNIV TOKYO·Filed 2015·Granted Jan 29, 2019·3 cites·11 claims
- 0771US2023112275A1Inferring device, inferring method, structural formula, and non-transitory computer readable mediumPREFERRED NETWORKS INC·Filed 2022·Application pending·0 cites
- 0869US10183949B2Pyrimidinone derivative having autotaxin-inhibitory activityUNIV TOKYO·Filed 2017·Granted Jan 22, 2019·1 cites·16 claims
- 0957US2023196075A1Inferring device, training device and inferring methodPREFERRED NETWORKS INC·Filed 2023·Application pending·0 cites
- 1057US2020080067A1Crispr-cas systems, crystal structure and uses thereofBROAD INST INC·Filed 2019·Application pending·0 cites
- 1156US11155795B2CRISPR-Cas systems, crystal structure and uses thereofBROAD INST INC·Filed 2016·Granted Oct 26, 2021·0 cites·6 claims
- 1255US2023095369A1Inferring device, training device, inferring method, training method, and non-transitory computer readable mediumPREFERRED NETWORKS INC·Filed 2022·Application pending·0 cites
- 1341US2016002247A18-substituted imidazopyrimidinone derivative having autotaxin inhibitory activityUNIV TOKYO·Filed 2014·Application pending·0 cites
- 1437US2018201912A1Modified fncas9 protein and use thereofUNIV TOKYO·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →